![]() |
市場調查報告書
商品編碼
2026912
多通道動物麻醉設備市場預測至 2034 年—按類型、目標動物、應用和地區進行全球分析。Multi Channel Animal Anesthesia Machine Market Forecasts to 2034 - Global Analysis By Type (Mobile Type and Desktop Type), Animal Type (Small Animals, Exotic Animals and Large Animals), Application and By Geography |
||||||
根據 Stratistics MRC 的數據,全球多通道動物麻醉設備市場預計到 2026 年將達到 4 億美元,並在預測期內以 8.9% 的複合年成長率成長,到 2034 年達到 8 億美元。
多通道動物麻醉系統是一種專用醫療設備,旨在為科研和獸醫環境中的多隻動物同時進行精準麻醉。這些先進的設備能夠對麻醉藥物的輸送進行個別化控制,並適用於各種物種和體型的動物。這使得研究人員和獸醫能夠對不同的動物群體進行實驗和操作,從而確保麻醉管理的準確性和人道性。
根據世界衛生組織統計,癌症是死亡的主要原因,2020 年估計造成 1,000 萬人死亡。
人們日益關注動物福利
多通道動物麻醉機在精確控制麻醉給藥、最大限度減少接受醫療手術動物的壓力和不適方面發揮著至關重要的作用。在實驗室和獸醫領域,社會各界越來越關注科研和獸醫實踐中動物的倫理待遇,並將減輕動物的疼痛和痛苦放在首位。此外,這種意識的增強使得遵守倫理指南、促進負責任且人道的動物實驗成為研究人員、獸醫和醫療機構的重要考慮因素,從而推動了市場成長。
成本限制
由於設計複雜、組件要求高且必須嚴格遵守安全法規,多通道動物麻醉設備的製造成本可能很高。動物麻醉設備的特定市場及其有限的規模經濟也會影響成本結構。此外,對於某些客戶而言,設備的高昂初始成本、持續維護的需求以及操作所需的專業培訓都可能構成經濟負擔,從而可能阻礙市場擴張。
技術進步
自動化和智慧技術的整合有助於提高安全性,並使研究人員和獸醫能夠更精確地監測和調整麻醉參數。這些麻醉系統在設計和功能上的持續創新,提升了其性能、效率和易用性。此外,與數位平台和連接解決方案的整合,實現了無縫的資料傳輸和遠端監控,從而提高了整體工作流程效率。這不僅滿足了研究人員和獸醫的多樣化需求,也有助於推動動物照護和實驗中人道和倫理實踐的發展,從而推動市場成長。
缺乏標準化
由於缺乏標準化的操作規程,不同製造商的設備操作流程可能存在差異,這給使用者培訓和教育帶來了困難。多通道麻醉設備的設計、校準和操作缺乏普遍認可的標準,為製造商、使用者和監管機構都帶來了挑戰。因此,這種不統一性會阻礙研究人員、獸醫和醫療機構之間資訊的順暢交流和最佳實踐的分享,從而影響整體操作效率。
新冠疫情的影響
新冠疫情對多通路動物麻醉設備市場造成了許多負面影響。供應鏈中斷、非必要活動受限以及經濟不確定性顯著影響了市場動態。許多研究機構和獸醫診所面臨預算限制,必須將資源轉移到應對疫情帶來的緊迫挑戰上,導致設備採購和升級放緩。此外,獸醫診所病例數量的減少,尤其是擇期手術病例的減少,也影響了對先進麻醉設備的需求,進而阻礙了市場成長。
在預測期內,外來動物市場預計將佔據最大佔有率。
據估計,異寵麻醉領域佔最大的市場佔有率。這些儀器能夠滿足不同物種的麻醉需求,並確保手術過程中的精準控制和監測。這些儀器提供多方面的解決方案,可適應各種動物的體型和生理需求,從小型囓齒動物到大型野生哺乳動物均適用。此外,技術進步催生了精密的麻醉管理系統,使得在實驗環境中能夠進行高效且個人化的麻醉管理,推動了該領域的成長。
在預測期內,科研實驗室領域預計將呈現最高的複合年成長率。
預計在預測期內,科學研究實驗室領域將呈現最高的複合年成長率,因為作為生物醫學和製藥研究(包括動物實驗)的重要組成部分,其需求正顯著成長。研究人員利用這些設備同時維持多個受試者的麻醉狀態,並促進需要複雜實驗設計和多種動物模型的研究。此外,這些設備提供了一個高度可客製化的平台,使科學家能夠根據不同物種獨特的生理需求,使用高品質、多功能的麻醉解決方案來客製化麻醉給藥方案,這推動了該領域的擴張。
在預測期內,歐洲佔了最大的市場佔有率,這主要得益於獸醫學和研究的進步,以及人們對動物福利日益成長的關注。英國、德國、義大利、法國和西班牙等國家正大力推廣多通道麻醉設備,並將其應用於各種領域。這些設備能夠滿足不同體型和物種的特定需求,這與該地區致力於人道和負責任的動物實驗(包括獸醫學、生物醫學研究和學術研究)的理念相契合,而這正是推動該地區市場成長的關鍵因素。
預計北美地區在預測期內將實現最高的複合年成長率。這些先進設備能夠精確、同步地控制麻醉劑的給藥,適用於包括伴侶動物、實驗動物和野生動物在內的多種動物。肯特科學公司(Kent Scientific Corporation)、哈佛儀器公司(Harvard Apparatus)、RWD生命科學公司和SurgiVet等領導者正致力於生物醫學和獸醫學研究,並持續推出先進的功能和性能。此外,伴侶動物慢性疾病的普遍存在以及動物模型在藥物研發中日益重要的作用,也推動了該地區的持續成長。
According to Stratistics MRC, the Global Multi Channel Animal Anesthesia Machine Market is accounted for $0.4 billion in 2026 and is expected to reach $0.8 billion by 2034 growing at a CAGR of 8.9% during the forecast period. A Multi Channel Animal Anesthesia Machine is a specialized medical device designed for administering precise and simultaneous anesthesia to multiple animal subjects in research and veterinary settings. This sophisticated equipment offers tailored control over anesthesia delivery, accommodating various species and sizes, which enable researchers and veterinarians to conduct experiments and procedures on diverse animals, ensuring accurate and humane anesthesia management.
According to the WHO, cancer is the leading cause of extinctionaly and was responsible for an estimated 10 million deaths in 2020.
Growing awareness of animal welfare
Multi-channel animal anesthesia machines play a crucial role by offering precise control over anesthesia administration, minimizing stress and discomfort for animals undergoing medical procedures. There are increasing societal concerns about the ethical treatment of animals in research and veterinary practices that prioritize the reduction of pain and distress in laboratory and veterinary settings. Furthermore, as awareness increases, adherence to ethical guidelines and the promotion of responsible and humane animal experimentation have become key considerations for researchers, veterinarians, and institutions, which are propelling this market growth.
Cost constraints
Higher manufacturing costs may result from the complex engineering, high-quality parts, and strict adherence to safety regulations involved in the production of multi-channel animal anesthesia machines. The specific market for animal anesthesia machines and its constrained economies of scale can also have an effect on the cost structure. In addition, for certain customers, the machines' high initial costs, continuous maintenance requirements, and requirement for specialized training to operate them can be financially challenging, thereby hindering this market expansion.
Technological advancements
Automation and integration of smart technologies contribute to improved safety, allowing researchers and veterinarians to monitor and adjust anesthesia parameters with greater accuracy. Continuous innovation in the design and functionality of these anesthesia systems enhances their capabilities, efficiency, and user-friendliness. Furthermore, integration with digital platforms and connectivity solutions enables seamless data transfer and remote monitoring, enhancing overall workflow efficiency that not only meets the diverse needs of researchers and veterinarians but also contributes to the advancement of humane and ethical practices in animal care and experimentation, which are driving this market size.
Limited standardization
The absence of standardized protocols also complicates the training and education of users, as procedures may differ between machines from various manufacturers. The absence of universally accepted standards for the design, calibration, and operation of multi-channel anesthesia machines can create challenges for manufacturers, users, and regulatory bodies. Therefore, this lack of uniformity can impede the seamless exchange of information and best practices among researchers, veterinarians, and institutions, affecting the overall efficiency of operations.
Covid-19 Impact
The COVID-19 pandemic had various detrimental effects on the market for multichannel animal anesthesia machines. The disruptions in the supply chain, restrictions on non-essential activities, and economic uncertainties significantly affected the market dynamics. Many research institutions and veterinary facilities faced budget constraints and redirected resources toward addressing the immediate challenges posed by the pandemic, leading to a slowdown in equipment purchases and upgrades. In addition, veterinary clinics, particularly those handling elective procedures, witnessed a decrease in caseloads, impacting the need for sophisticated anesthesia equipment and thereby impeding this market size.
The exotic animals segment is expected to be the largest during the forecast period
The exotic animals segment is estimated to hold the largest share. These are the unique anesthesia requirements of diverse species, ensuring precise control and monitoring during procedures. These machines offer a multi-faceted approach, accommodating various animal sizes and species-specific physiological needs, ranging from small rodents to large non-domesticated mammals. Furthermore, advancements in technology have led to the development of sophisticated anesthesia delivery systems that enable efficient and tailored anesthesia management in experimental settings, thereby propelling this segment's growth.
The scientific research laboratory segment is expected to have the highest CAGR during the forecast period
The scientific research laboratory segment is anticipated to have highest CAGR during the forecast period, due to a significant upswing as a critical component in advancing biomedical and pharmaceutical research involving animal subjects. Researchers utilize these machines to maintain anesthesia across multiple subjects simultaneously, facilitating studies that require intricate experimental designs and varied animal models. In addition, these provide a sophisticated and adjustable platform, allowing scientists to customize anesthesia delivery based on the unique physiological needs of different species using high-quality, multi-functional anesthesia solutions, which are boosting this segment's expansion.
Europe commanded the largest market share during the extrapolated period owing to advancements in veterinary medicine, research, and a heightened focus on animal welfare. Countries including the UK, Germany, Italy, France, and Spain are increasingly adopting multi-channel anesthesia machines for diverse applications. These are capable of accommodating various animal sizes and species-specific requirements and align with the region's commitment to humane and responsible animal experimentation involving veterinary practices, biomedical research, and academic studies, which are driving this region's growth.
North America is expected to witness highest CAGR over the projection period. These sophisticated devices provide precise and simultaneous control over anesthesia administration, accommodating diverse animal species, including companion animals, laboratory animals, and wildlife. Key players such as Kent Scientific Corporation, Harvard Apparatus, RWD Life Science, and SurgiVet contribute to biomedical studies and veterinary research to introduce advanced features and functionalities. Additionally, the prevalence of chronic diseases in companion animals and the increasing importance of animal models in drug development contribute to the sustained growth that is boosting this region's growth.
Key players in the market
Some of the key players in the Multi Channel Animal Anesthesia Machine Market include Animalab, Scintica, Scitech Korea Inc., RWD Life Science, BiosebLab, Veterian Key, Parkland Scientific, SOMNI Scientific, ConductScience, World Precision Instruments, Dolphinmed, Comen, Yuyan Instruments, Bilead Biosci, Midmark Corporation and Hallowell EMC.
In October 2023, World Precision Instruments (WPI) is excited to expand the capability of the EVOM(TM) Auto, now offering both 24 and 96 multiwell capacity in one single platform.
In October 2023, Scintica is thrilled to announce the appointment of Dr. Jorg Hamm as a new Preclinical Imaging Product Specialist in our Netherlands office, fortifying our commitment to advancing scientific research and medicine.
In April 2023, World Precision Instruments (WPI) is excited to launch the newest member to its EVOM(TM) family of products, the EVOM(TM) Auto.
In February 2023, Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Poietis, manufacturer of the New Generation Bioprinting (NGB) system designed for translational research and regenerative medicine applications.